1. Home
  2. COLL

as 03-25-2025 10:33am EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Founded: 2002 Country:
United States
United States
Employees: N/A City: STOUGHTON
Market Cap: 910.2M IPO Year: 2015
Target Price: $43.60 AVG Volume (30 days): 506.2K
Analyst Decision: Strong Buy Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 1.86 EPS Growth: 43.56
52 Week Low/High: $27.28 - $42.29 Next Earning Date: 05-08-2025
Revenue: $631,449,000 Revenue Growth: 11.41%
Revenue Growth (this year): 19.43% Revenue Growth (next year): 3.34%

COLL Daily Stock ML Predictions

Stock Insider Trading Activity of Collegium Pharmaceutical Inc. (COLL)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Dreyer Scott COLL EVP & Chief Commercial Officer Mar 20 '25 Sell $30.01 20,808 $624,794.18 103,613
Tupper Colleen COLL EVP & Chief Financial Officer Mar 14 '25 Sell $30.00 977 $29,313.32 164,269
Dreyer Scott COLL EVP & Chief Commercial Officer Mar 11 '25 Sell $30.00 30,774 $923,343.10 103,613
Tupper Colleen COLL EVP & Chief Financial Officer Mar 11 '25 Sell $30.01 10,445 $313,412.67 164,269
Dreyer Scott COLL EVP & Chief Commercial Officer Mar 6 '25 Sell $30.00 5,643 $169,299.49 103,613
Tupper Colleen COLL EVP & Chief Financial Officer Mar 6 '25 Sell $30.00 3,453 $103,591.05 164,269
Kuhlmann Shirley R. COLL EVP and General Counsel Mar 4 '25 Sell $28.20 86,067 $2,426,633.99 108,137
Kuhlmann Shirley R. COLL EVP and General Counsel Jan 10 '25 Sell $33.26 27,500 $908,627.77 108,137

Share on Social Networks: